Why the study?
It remained unclear whether a fixed-period increase in the triglyceride glucose-waist height ratio index, reflecting short-term metabolic worsening, is associated with future cardiovascular disease risk.
Does a higher two-year increase in the triglyceride glucose‒waist height ratio (TyG‒WHtR) index increase the risk of major adverse cardiovascular events in a community-based population without prior stroke or MI?
Cohort (n=3,466)
No
Does a higher two-year increase in the triglyceride glucose‒waist height ratio (TyG‒WHtR) index increase the risk of major adverse cardiovascular events in a community-based population without prior stroke or MI?
Effect estimate: HR 1.30 (95% CI 1.00-1.69)
A short-term increase in the TyG-WHtR index, reflecting metabolic worsening, is associated with a higher risk of future MACE, an effect partially mediated by concurrent increases in mean arterial pressure.
It remains unclear whether a fixed-period increase in the triglyceride glucose‒waist height ratio (TyG‒WHtR) index, an indicator of short-term metabolic worsening, is associated with future cardiovascular disease (CVD) risk. To investigate this, we conducted a prospective cohort study in a Beijing community-based population in China, enrolling participants without a history of stroke or myocardial infarction (MI). The primary outcome was major adverse cardiovascular events (MACEs), defined as a composite of MI, stroke, and cardiovascular death. We employed Cox proportional hazards models with landmark analysis to evaluate the association. Among 3466 individuals followed for a median of 7.52 years since 2014, 270 MACE events occurred. Our analysis suggested a potential threshold effect, with CVD risk increasing more markedly when the TyG-WHtR increase exceeded approximately 0.400. Using this cutoff, individuals with a higher two-year increase in TyG-WHtR had a 30% higher risk of MACE (hazard ratio [HR] 1.30, 95% confidence interval [CI] 1.00-1.69) compared to those with lower increase. Landmark analysis revealed no significant association during the first 2 years; however, beyond this period, the association emerged, with an HR of 1.41 (95% CI 1.06-1.89). Further mediation analysis revealed that concurrent changes in mean arterial pressure (MAP) explained 30.4% of the association between changes in TyG-WHtR and MACEs. In conclusion, an increase in TyG-WHtR reflecting short-term metabolic worsening, is associated with an increased MACE risk, and this relationship appears to be partly mediated by changes in MAP.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) conducted a cohort in Cardiovascular disease risk (n=3,466). Higher two-year increase in TyG-WHtR (>0.400) vs. Lower increase in TyG-WHtR was evaluated on Major adverse cardiovascular events (MACEs), defined as a composite of MI, stroke, and cardiovascular death (HR 1.30, 95% CI 1.00-1.69).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: